Current and future applications of biomedical engineering for proteomic profiling: Predictive biomarkers in neuro-traumatology

Journal article

This systematic review aims to summarize the impact of nanotechnology and biomedical engineering in defining clinically meaningful predictive biomarkers in patients with traumatic brain injury (TBI), a critical worldwide health problem with an estimated 10 billion people affected annually worldwide. Data were collected through a review of the existing English literature performed on Scopus, MEDLINE, MEDLINE in Process, EMBASE, and/or Cochrane Central Register of Controlled Trials. Only experimental articles revolving around the management of TBI, in which the role of new devices based on innovative discoveries coming from the field of nanotechnology and biomedical engineering were highlighted, have been included and analyzed in this study. Based on theresults gathered from this research on innovative methods for genomics, epigenomics, and proteomics, their future application in this field seems promising. Despite the outstanding technical challenges of identifying reliable biosignatures for TBI and the mixed nature of studies herein described (single cells proteomics, biofilms, sensors, etc.), the clinical implementation of those discoveries will allow us to gain confidence in the use of advanced neuromonitoring modalities with a potential dramatic improvement in the management of those patients.

Authors: Ganau, M; Syrmos, N; Paris, M; Ganau, L; Ligarotti, G

• Publication status: Published
• Peer review status: Peer reviewed
• Publisher: MDPI
• Journal: Medicines
• Volume: 5
• Issue: 1
• Pages: 19
• Publication date: 2018-02-05
• Acceptance date: 2018-01-30
• DOI: 10.3390/medicines5010019
• EISSN: 2305-6320
• Pmid: 29401743
• Language: English
• Keywords: microRNA; proteomics; biomarkers; traumatic brain injury; mass spectroscopy